ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07AH08 | B | Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml | 11243 | 43320 | NIMENRIX | 1 + 1 x 0.5ml | Injectable lyophilised powder for solution+diluent | IM | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 4,483,059 L.L | 23.08 | B | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |